Dermatology Scheduling Triage of Transplant Patients and Transplant Candidates to Improve Early Diagnosis and Prevention of Skin Cancer: International Immunosuppression and Transplant Skin Cancer Collaborative Expert Consensus Recommendations

TY - JOUR

T1 - Dermatology Scheduling Triage of Transplant Patients and Transplant Candidates to Improve Early Diagnosis and Prevention of Skin Cancer

T2 - International Immunosuppression and Transplant Skin Cancer Collaborative Expert Consensus Recommendations

AU - Hirotsu, Kelsey E.

AU - Crowe, Lauren

AU - Michalski-McNeely, Basia

AU - Arron, Sarah T.

AU - Bibee, Kristin

AU - Bottomley, Matthew J.

AU - Carr, David R.

AU - Carter, Joi B.

AU - Christensen, Sean R.

AU - Chung, Christina

AU - Jambusaria, Anokhi

AU - Ken, Kimberly M.

AU - Loss, Manisha J.

AU - Paragh, Gyorgy

AU - Plasmeijer, Elsemieke I.

AU - Proby, Charlotte

AU - Pugliano-Mauro, Melissa

AU - Shahwan, Kathryn T.

AU - Whitley, Melodi Javid

AU - Carroll, Bryan T.

N1 - Publisher Copyright: Copyright © 2025 Hirotsu, Crowe, Michalski-McNeely, Arron, Bibee, Bottomley, Carr, Carter, Christensen, Chung, Jambusaria, Ken, Loss, Paragh, Plasmeijer, Proby, Pugliano-Mauro, Shahwan, Whitley and Carroll.

PY - 2025/9/11

Y1 - 2025/9/11

N2 - Solid organ transplant recipients (SOTRs) have a high risk of developing aggressive skin cancers. However, there are no standardized triage guidelines to assist dermatology clinics with scheduling new patients pre- or post-transplant. Dermatologic care of SOTRs requires multidisciplinary coordination, extensive assessment, tailored counseling, and longitudinal care. Specialized high-risk transplant clinics are designed to address this clinical need but are a limited resource. This triage algorithm aims to provide a practical framework for tertiary care centers or community practice clinics receiving pre- or post-transplant referrals for active concerning growths or routine skin cancer screening exams. In summary, our expert panel recommends SOTRs are seen within 1–2 weeks for evaluation of an active growth and triaged according to their risk factors for the initial post-transplant screening visit (6 months–2+ years post-transplant). Transplant candidates should be seen for pre-transplant evaluation within 1 month of the referral for a skin cancer screening exam, depending on the transplant team’s timeline and dermatologist availability. Overall, dermatologists face numerous challenges in caring for transplant patients, and scheduling these patients in a timely manner according to the acuity of their needs will facilitate prevention and early diagnosis of skin cancer, thus improving transplant patient outcomes.

AB - Solid organ transplant recipients (SOTRs) have a high risk of developing aggressive skin cancers. However, there are no standardized triage guidelines to assist dermatology clinics with scheduling new patients pre- or post-transplant. Dermatologic care of SOTRs requires multidisciplinary coordination, extensive assessment, tailored counseling, and longitudinal care. Specialized high-risk transplant clinics are designed to address this clinical need but are a limited resource. This triage algorithm aims to provide a practical framework for tertiary care centers or community practice clinics receiving pre- or post-transplant referrals for active concerning growths or routine skin cancer screening exams. In summary, our expert panel recommends SOTRs are seen within 1–2 weeks for evaluation of an active growth and triaged according to their risk factors for the initial post-transplant screening visit (6 months–2+ years post-transplant). Transplant candidates should be seen for pre-transplant evaluation within 1 month of the referral for a skin cancer screening exam, depending on the transplant team’s timeline and dermatologist availability. Overall, dermatologists face numerous challenges in caring for transplant patients, and scheduling these patients in a timely manner according to the acuity of their needs will facilitate prevention and early diagnosis of skin cancer, thus improving transplant patient outcomes.

KW - dermatology

KW - melanoma

KW - scheduling

KW - skin cancer

KW - squamous cell carcinoma

KW - SUNTRAC

KW - transplant assessment

KW - triage

UR - https://www.scopus.com/pages/publications/105017416622

U2 - 10.3389/ti.2025.14711

DO - 10.3389/ti.2025.14711

M3 - Article

C2 - 41018279

AN - SCOPUS:105017416622

SN - 0934-0874

VL - 38

JO - Transplant International

JF - Transplant International

M1 - 14711

ER -